Information for Prescribers

Essential resources and guidance to support safe, informed prescribing of pharmaceutical-grade Dronabinol therapies.

Supporting Safe and Informed Prescribing 

At Dunbar Pharmaceuticals, we’re committed to equipping healthcare professionals with the data, documentation, and pharmaceutical confidence needed to safely prescribe cannabinoid-based therapies.

Our pharmaceutical-grade Dronabinol API (delta-9-THC) is manufactured in compliance with EU Good Manufacturing Practices (GMP) and is available for magistral preparation or compounding by pharmacists in approved jurisdictions.

An out of focus process scientist in full GMP cleanroom PPE, showing a close up of a syringe containing pharmaceutical-grade EU-GMP dronabinol API manufactured by Dunbar Pharma.

About Dunbar Dronabinol API

  • API Name: Dronabinol (Plant-Derived)
  • CAS Number: 1972-08-3
  • Molecular Formula: C₂₁H₃₀O₂
  • Purity: Among the highest on the market, exceeding DAC/NRF standards for use in magistral formulations
  • Stability: Long-term stability validated under ICH Q1A guidelines

Each batch is subject to full in-house QC testing, QA release, and certified batch documentation – delivered with validated COAs, test strip confirmations, and regulatory documentation to support insurance reimbursement and clinical safety reviews.

Dronabinol Information

Therapeutic Use 

Prescribing guidelines vary by country. Under appropriate frameworks, dronabinol is typically considered for the following indications:

  • Anorexia and weight loss associated with chronic illness (e.g. HIV/AIDS)
  • Chemotherapy-induced nausea and vomiting (CINV)
  • Chronic pain where conventional therapies are inadequate
  • Off-label (in select jurisdictions): Spasticity in multiple sclerosis and other neurological conditions

Always refer to national controlled substance/narcotic regulations and prescribing protocols in your region.

Documentation & Resources 

Healthcare providers can access a suite of up-to-date documents to support prescribing decisions:

Certificates of Analysis

Summary of Product Characteristics

Compounding & Formulation Guidelines

GMP Certificate and Regulatory Statement

For additional clinical support or documentation requests, please contact us directly at info@dunbarpharma.ie or visit our contact page to submit an enquiry using our contact form.

Get In Touch With Us

Have a question or partnership inquiry? Contact our team, we’re here to help.